Oncology therapeutics VC daily
activeAudience: an oncology-focused biotech venture capitalist with technical depth. Commentary should assume an appropriate level of context.
Conversational, precise, and audio-first. Make the briefing feel like a thoughtful private intelligence memo spoken aloud.
2 employed reporters18 minute target
